Cramer: PMs could double down on this stock By: CNBC.com News September 17, 2013 at 18:42 PM EDT Up 54% ytd, if pros must buy health care, Cramer thinks they'll take a long hard look at this stock. Get details, now! Read More >> Related Stocks: Biomarin Pharmaceuticals